Design
Review
Authors
Loading...
PK differences inform dosing and monitoring; leaves open comparative outcome trials versus modern therapies.
Understanding the distinct pharmacokinetic profiles of digoxin and digitoxin, including absorption, half-life, and optimal serum levels, is essential for safe and effective dosing.
James E. Doherty (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: